611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Depression: Depression & Related Conditions
Resources
Basic Information
Introduction and Types of Depressive DisordersRelated Disorders / ConditionsHistorical and Current UnderstandingsBiology, Psychology and SociologyTreatment - Medication and PsychotherapyAlternative Medicine and Self-Help ResourcesSpecial IssuesReferences
More InformationTestsLatest News
One-Third of Lung Cancer Patients Battle Depression: StudyAnother Downside to Vaping: Higher Odds for DepressionCan You Beat the Blues With 'Downward Dog'?Exercise Can Help Prevent Depression, Even for Those at High RiskWhat Works Best to Treat Depression?Depression Rates Not Budging for Lesbian and Gay TeensDon't Let SAD Get the Better of YouAntidepressants Might Raise Odds for Serious Pregnancy ComplicationDepressed Moms, More Anxious, Troubled Kids?Why You Should Ask to Be Screened for Postpartum DepressionCommon Antidepressants May Work in Unexpected Way: StudyExperimental Drug Works Quickly on Major DepressionExercise Your Blues AwayDepression, Alzheimer's Might Be Part of Same Process in Some Aging Brains: StudyToo Much Social Media a Depression Risk for TeensEasing Depression Can Bring Longer Life to People With DiabetesIs Your Child Depressed or Suicidal? Here Are the Warning SignsDepression Plus HIV Can Turn DeadlyBrain Stimulation May Soothe Severe DepressionFussy Baby May Raise Mom's Risk of DepressionAbuse in Childhood Tied to Brain Changes and Later DepressionFDA Approves First Drug for Postpartum DepressionNutritional Supplements Don't Ward Off Depression: StudyFDA Approves Ketamine-Like Drug for Severe DepressionFDA Poised to Approve Ketamine-Like Drug to Ease DepressionAcne Drug Accutane May Not Depress Mood After AllHealth Tip: Beat the Winter BluesAHA News: Post-Stroke Depression Common Among Black, Hispanic SurvivorsHealth Tip: Recognizing Signs of Depression in TeensCould Germs in Your Gut Send You Into Depression?Simple Treatments to Banish Winter BluesMillennials' Odds for Depression Rise With Social Media UseListen Up! Hearing Loss Tied to Late-Life DepressionHealth Tip: Risk Factors for Depression After PregnancyHead to the Movies, Museums to Keep Depression at BayMany Say Ketamine Eased Their Depression, But Is It Safe?Preventive Intervention for Premature Infants EffectiveDepression News Feed
Questions and AnswersLinksBook Reviews
Related Topics

Anxiety Disorders
Bipolar Disorder
Suicide
Addictions: Alcohol and Substance Abuse
Pain Management

What Works Best to Treat Depression?

HealthDay News
by By Amy NortonHealthDay Reporter
Updated: Oct 28th 2019

new article illustration

MONDAY, Oct. 28, 2019 (HealthDay News) -- "Talk therapy" for depression may cost more than medication initially, but in the long run, both may have a similar payoff, a new study finds.

The study estimated the cost-effectiveness of the two treatments. It found that over one year, antidepressants offered more value for the money. But when the researchers looked at the five-year picture, talk therapy seemed to provide more benefit for the cost.

Experts said the point is not to declare a "winner" in the realm of depression treatment.

Instead, the findings support guidelines saying that antidepressants and cognitive behavioral therapy (CBT) are both "reasonable" choices as an initial therapy, said study leader Dr. Eric Ross.

What's important for patients is that they know there is more than one effective option, according to Ross, a psychiatrist with McLean Hospital in Belmont, Mass., and Massachusetts General Hospital, in Boston.

Dr. Mark Sinyor, a psychiatrist at Sunnybrook Health Sciences Centre, in Toronto, agreed that there is no one-size-fits-all.

A patient's personal preferences are a critical piece, said Sinyor, who wrote an editorial published with the findings Oct. 28 in the Annals of Internal Medicine.

"If someone doesn't want CBT," he said, "it's unlikely to help, since you have to engage with it."

There's also the matter of depression severity: CBT and antidepressants are, on average, equally effective for milder to moderate depression, Sinyor explained, but people with severe symptoms typically need medication.

"Depression can make you feel hopeless," he said. "But we do have effective treatments, and if one doesn't help you, we can try another."

CBT is not the only form of psychotherapy for depression, but it is well-studied and recommended in guidelines. It involves individual or group sessions with a therapist. Simply put, the goal is to identify and reshape the negative thought patterns that may be driving depression symptoms, and develop healthier ways of coping.

Up front, CBT costs a lot more than medications, which are often available as a generic. A single session costs upwards of $100, versus $100 a year for many antidepressants, Ross and his team pointed out.

But people usually have a limited number of CBT sessions, and over time, the cost-effectiveness shifts, the new analysis suggests. In the first year, medication generally provided a greater "net monetary benefit" -- a measure that considers how much money has to be spent to gain a year of life in good health, the researchers noted.

But at year five, CBT generally offered a greater benefit for the money. The researchers projected that at that point, health care costs could be up to $1,800 lower for every patient treated with CBT; the finding was not significant in statistical terms, however, which indicates some uncertainty, the study authors said.

A caveat is that the projections are based on statistical modeling. The researchers used data from past studies and real-world cost figures to make estimates on cost-effectiveness. They had to make certain assumptions -- that CBT, for instance, would involve four individual sessions and eight group sessions over three months, and then individual sessions once a month.

Using study data, they projected that about 40% of first-time antidepressant patients would see their symptoms go away, and about 63% would show an improvement. Those success rates would be similar among CBT patients, but at a greater initial cost.

However, when the researchers weighed other evidence -- patients on medication being more likely to relapse, for example -- antidepressants were not more cost-effective in the long run.

According to Ross, research has found that most people with depression would prefer to try talk therapy first. Yet less than one-quarter of U.S. patients get it.

There can be big obstacles, Ross said. People may live far from a CBT provider, or be unable to manage the time commitment.

So the mental health system may need to get creative. Sinyor pointed to one potential solution: training non-psychologists, such as social workers, to deliver CBT.

Technology could also help, he and Ross said, by, for instance, allowing patients in rural areas to receive CBT by video chat. However, Sinyor added, while that might work for some people, there will always be those who need face-to-face counseling.

More information

There's more on depression at the U.S. National Institute of Mental Health.